Brown James A, Kilic Arman, Aranda-Michel Edgar, Serna-Gallegos Derek, Habertheuer Andreas, Bianco Valentino, Thoma Floyd W, Navid Forozan, Sultan Ibrahim
Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania.
Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
J Card Surg. 2020 Aug;35(8):1920-1926. doi: 10.1111/jocs.14852. Epub 2020 Jul 11.
Redo cardiac surgery carries an inherent risk for adverse short-term outcomes and worse long-term survival. Strategies to mitigate these risks have been numerous, including initiation of cardiopulmonary bypass via peripheral cannulation before resternotomy. This study evaluated the impact of central versus peripheral cannulation on long-term survival after redo cardiac surgery.
This was an observational study of open cardiac surgeries between 2010 and 2018. Patients undergoing open cardiac surgery that utilized cardiopulmonary bypass, who also had more than equal to 1 prior cardiac surgery, were identified. Kaplan-Meier survival estimation and multivariable Cox regression analysis were performed to assess the impact of peripheral cannulation on survival. To isolate long-term survival, patients with operative mortality were excluded and survival time was counted from the date of discharge until the date of death.
Of the 1660 patients with more than equal to 1 prior cardiac surgery, 91 (5.5%) received peripheral cannulation. After excluding patients with operative mortality and after multivariable risk-adjustment, the peripheral cannulation group had significantly increased hazard of death, as compared to the central cannulation group (HR 1.53, 95% CI: 1.01, 2.30, P = .044). Yet, there were no relevant differences for other postoperative outcomes, including blood product requirement, prolonged ventilation (>24 hours), pneumonia, reoperation for bleeding, stroke, sepsis, and new dialysis requirement.
This is the first study reporting the long-term impact of peripheral cannulation for redo cardiac surgery after excluding patients with operative mortality. These data suggest that central cannulation may to be the preferred approach to redo cardiac surgery whenever safe and possible.
再次心脏手术存在短期不良后果和长期生存率较低的固有风险。降低这些风险的策略有很多,包括在再次胸骨切开术前通过外周插管启动体外循环。本研究评估了中心插管与外周插管对再次心脏手术后长期生存的影响。
这是一项对2010年至2018年开放性心脏手术的观察性研究。确定接受使用体外循环的开放性心脏手术且既往有至少1次心脏手术的患者。进行Kaplan-Meier生存估计和多变量Cox回归分析,以评估外周插管对生存的影响。为了分离长期生存情况,排除手术死亡患者,生存时间从出院日期计算至死亡日期。
在1660例既往有至少1次心脏手术的患者中,91例(5.5%)接受了外周插管。排除手术死亡患者并进行多变量风险调整后,与中心插管组相比,外周插管组的死亡风险显著增加(风险比1.53,95%置信区间:1.01,2.30,P = 0.044)。然而,在其他术后结局方面没有相关差异,包括血液制品需求、通气延长(>24小时)、肺炎、因出血再次手术、中风、败血症和新的透析需求。
这是第一项在排除手术死亡患者后报告外周插管对再次心脏手术长期影响的研究。这些数据表明,只要安全可行,中心插管可能是再次心脏手术的首选方法。